QUILT-2.014: Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Clinical trial NCT01231347 · COMPLETED
Trial details
- NCT number
- NCT01231347
- Sponsor
- NantCell, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-04-07
- Primary completion
- 2012-12-12
- Enrollment
- 800
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.